Literature DB >> 34023250

Multimodality Imaging Assessment of Myocardial Fibrosis.

Sumit Gupta1, Yin Ge2, Amitoj Singh3, Christoph Gräni3, Raymond Y Kwong4.   

Abstract

Myocardial fibrosis, seen in ischemic and nonischemic cardiomyopathies, is associated with adverse cardiac outcomes. Noninvasive imaging plays a key role in early identification and quantification of myocardial fibrosis with the use of an expanding array of techniques including cardiac magnetic resonance, computed tomography, and nuclear imaging. This review discusses currently available noninvasive imaging techniques, provides insights into their strengths and limitations, and examines novel developments that will affect the future of noninvasive imaging of myocardial fibrosis.
Copyright © 2021 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  T1 mapping; cardiac computed tomography; cardiac magnetic resonance; late gadolinium enhancement; myocardial fibrosis; nuclear imaging

Mesh:

Substances:

Year:  2021        PMID: 34023250     DOI: 10.1016/j.jcmg.2021.01.027

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  2 in total

1.  Empagliflozin reduces diffuse myocardial fibrosis by extracellular volume mapping: A meta-analysis of clinical studies.

Authors:  Haipeng Wang; Lin Ding; Liwen Tian; Yutian Tian; Lin Liao; Junyu Zhao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-11       Impact factor: 6.055

Review 2.  Detection of myocardial fibrosis: Where we stand.

Authors:  Leyi Zhu; Yining Wang; Shihua Zhao; Minjie Lu
Journal:  Front Cardiovasc Med       Date:  2022-09-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.